Hemabate

   
Google
 
Web NewDrugInformation.com

Hemabate


Drug - Hemabate
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Carboprost Tromethamine
Multiple ingredients are in alphabetical order.

Strength - EQ 0.25MG BASE/ML
The potency of the active ingredient(s), Carboprost Tromethamine. May repeat for multiple part products.

Applicant - PHARMACIA AND UPJOHN
The firm name holding legal responsibility for Hemabate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 017989
The FDA assigned number to Hemabate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Hemabate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Hemabate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Hemabate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Hemabate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pharmacia And Upjohn Co
The full name of the firm holding legal responsibility for the new application of Hemabate.

Hemabate